Skip to main content

Changes to 49 CFR Part 40, Procedures for Transportation Workplace Drug and Alcohol Testing Programs Effective October 1, 2010


Mobile Medical Corporation (MMC)
 Drug Testing Industry Alert!

Introduction
The Omnibus Transportation Employees Testing Act (Omnibus Act) requires the Department of Transportation (DOT) to follow Department of Health and Human Services (DHHS) requirements for testing procedures/protocols and drugs. Most of the changes to 49 CFR Part 40 were made to meet specific DHHS guidelines for laboratory procedures, drug cut-off levels, and drugs. These guidelines apply to federal employees and employees in federally regulated industries, such as transportation and nuclear, as well as state regulations that mandate compliance with DHHS guidelines.

Changes
On October 1, 2010, The following changes to the DHHS and DOT drug testing panel will be required:

Amphetamines
§ Decrease the Amphetamines screening cutoff from 1000 ng/mL to 500 ng/mL;

§ Decrease the confirmation cutoff of both amphetamine and methamphetamine from 500 ng/mL to 250 ng/mL;

§ Only MDMA is added as a specific target drug for screening; MDMA, MDA and MDEA are included in confirmation testing.

Testing for MDMA (Ecstasy)
MDMA will be a target analyte in the amphetamines screening assay, with confirmation testing for MDMA, MDA, and MDEA.

6-Monoacetylmorphine (heroin metabolite)
§ Addition of a specific screening test for the heroin metabolite at 10 ng/mL cutoff concentration. This change requires a laboratory to confirm and report the heroin metabolite by itself, in contrast to the current Guidelines policy that requires the heroin metabolite to be tested and reported in conjunction with a positive morphine result. Recent data indicates that the heroin metabolite is present in
specimens even when the morphine concentration is below 2000 ng/mL.

Cocaine
§ Decrease the Cocaine metabolite screening cutoff from 300 ng/mL to 150 ng/mL

§ Decrease the Cocaine metabolite confirmation cutoff from 150ng/mL to 100ng/mL

How Will These Changes Affect You?
Although Non-DOT regulated testing programs are not required to implement these upcoming changes (except where required by law),

Industry consensus is that most non-DOT regulated program owners and employers will most likely make changes to follow the new

guidelines. As the new revisions will take effect soon you may need to consider a few issues regarding drug testing program.
Some issues to consider...

Will you revise your testing panel to comply with the new government revisions? Will adding the new screens increase costs?

Do you belong to an association, a labor-management cooperative program or other organization that requires you to follow DHHS guidelines? How will their changes affect or change your program?

Are you in a State with a “Drug Free Work Place” Program that requires you to mirror the new regulations in order to bid state funded projects?

Need Advice?
Part 40 Final Rule is effective October 1, 2010 and a copy of the Federal Register Notice is available on our Website under Latest News. DOT-regulated employers should ensure that their policies include the updated definitions, drugs tested for, and cut-off levels in their policy. If you have questions about the Part 40 Final Rule, please contact  877-688-8358.

Popular posts from this blog

PHOTOS: MMC Through the Years

Mobile Medical Corporation (MMC) is excited to be celebrating our 30th Anniversary in 2020! MMC was founded on June 21, 1990. Check out some photos as we have grown over the years!            
Read more

Synthetic Marijuana Making Local and National Headlines

Synthetic Marijuana, also known as "K-2" or "Spice" is a mixture of common herbs sprayed with synthetic chemicals that mirror the high of Marijuana. The synthetic product is sold as incense in head shops, tobacco stores and convenient stores. So far, twelve states have banned the sale of Synthetic Marijuana - (Kansas, Georgia, Alabama, Tennessee, Missouri, Louisiana, Mississippi, Arkansas, Oregon, Illinois, Michigan, and Kentucky). The American Association of Poison Control Centers reported that within the past year there have been over 500 cases of negative reactions to the still legal yet dangerous drug. On the national level the U.S. Drug Enforcement Administration (DEA) recently designated certain chemicals that are present within Synthetic Marijuana to the same category that heroin and LSD are part of and further emphasizes the need to be able to test blood and urine for Synthetic Marijuana use. On the local level- The Herald Online reported that Fort Mill,...
Read more

Random Drug Testing Benefits Employers

Drug testing programs aim to prevent the hiring of drug-using applicants while deterring drug use among current employees. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), 21.4 percent of employed adults used illicit drugs within the past month. Results from the 2014 Quest Diagnostics Drug Testing Index™ (DTI) show that, in the general U.S. workforce, random urine drug test positivity rates are higher (5.7 percent) than they are for pre-employment (4.0 percent) or periodic (1.6 percent). Random or “spot” drug testing works as a drug use deterrent because these programs are conducted in an unannounced and unpredictable manner. Utilizing a random drug testing program may help employers by: Deterring current employees from engaging in drug use Preventing the need for substance abuse recovery programs Helping reduce health insurance costs Improving attendance and employee productivity Providing a safer workplace with reduced accidents However, set...
Read more